174 related articles for article (PubMed ID: 23072704)
1. Identifying predictors of hepatic disease in patients after the Fontan operation: a postmortem analysis.
Johnson JA; Cetta F; Graham RP; Smyrk TC; Driscoll DJ; Phillips SD; John AS
J Thorac Cardiovasc Surg; 2013 Jul; 146(1):140-5. PubMed ID: 23072704
[TBL] [Abstract][Full Text] [Related]
2. Hepatic pathology may develop before the Fontan operation in children with functional single ventricle: an autopsy study.
Schwartz MC; Sullivan L; Cohen MS; Russo P; John AS; Guo R; Guttenberg M; Rand EB
J Thorac Cardiovasc Surg; 2012 Apr; 143(4):904-9. PubMed ID: 21955477
[TBL] [Abstract][Full Text] [Related]
3. Portal and centrilobular hepatic fibrosis in Fontan circulation and clinical outcomes.
Wu FM; Jonas MM; Opotowsky AR; Harmon A; Raza R; Ukomadu C; Landzberg MJ; Singh MN; Valente AM; Egidy Assenza G; Perez-Atayde AR
J Heart Lung Transplant; 2015 Jul; 34(7):883-91. PubMed ID: 25863891
[TBL] [Abstract][Full Text] [Related]
4. Fontan-associated liver disease: Spectrum of US findings.
Bae JM; Jeon TY; Kim JS; Kim S; Hwang SM; Yoo SY; Kim JH
Eur J Radiol; 2016 Apr; 85(4):850-6. PubMed ID: 26971434
[TBL] [Abstract][Full Text] [Related]
5. Portal and sinusoidal fibrosis are common on liver biopsy after Fontan surgery.
Schwartz MC; Sullivan LM; Glatz AC; Rand E; Russo P; Goldberg DJ; Rome JJ; Cohen MS
Pediatr Cardiol; 2013 Jan; 34(1):135-42. PubMed ID: 22695765
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and characterization of fibrosis in surveillance liver biopsies of patients with Fontan circulation.
Surrey LF; Russo P; Rychik J; Goldberg DJ; Dodds K; O'Byrne ML; Glatz AC; Rand EB; Lin HC
Hum Pathol; 2016 Nov; 57():106-115. PubMed ID: 27476041
[TBL] [Abstract][Full Text] [Related]
7. Late hepatic complications after Fontan operation; non-invasive markers of hepatic fibrosis and risk factors.
Baek JS; Bae EJ; Ko JS; Kim GB; Kwon BS; Lee SY; Noh CI; Park EA; Lee W
Heart; 2010 Nov; 96(21):1750-5. PubMed ID: 20956491
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of biomarkers of hepatic fibrosis in adult Fontan patients.
Wu FM; Earing MG; Aboulhosn JA; Johncilla ME; Singh MN; Odze RD; Ukomadu C; Gauvreau K; Landzberg MJ; Valente AM;
J Heart Lung Transplant; 2017 Feb; 36(2):211-219. PubMed ID: 27592026
[TBL] [Abstract][Full Text] [Related]
9. Early and late results of the modified fontan operation for heterotaxy syndrome 30 years of experience in 142 patients.
Bartz PJ; Driscoll DJ; Dearani JA; Puga FJ; Danielson GK; O'Leary PW; Earing MG; Warnes CA; Hodge DO; Cetta F
J Am Coll Cardiol; 2006 Dec; 48(11):2301-5. PubMed ID: 17161263
[TBL] [Abstract][Full Text] [Related]
10. Improving results of the Fontan procedure in patients with heterotaxy syndrome.
Kim SJ; Kim WH; Lim HG; Lee CH; Lee JY
Ann Thorac Surg; 2006 Oct; 82(4):1245-51. PubMed ID: 16996916
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with prolonged recovery after the fontan operation.
Salvin JW; Scheurer MA; Laussen PC; Mayer JE; Del Nido PJ; Pigula FA; Bacha EA; Thiagarajan RR
Circulation; 2008 Sep; 118(14 Suppl):S171-6. PubMed ID: 18824751
[TBL] [Abstract][Full Text] [Related]
12. Liver health in adults with Fontan circulation: A multicenter cross-sectional study.
Wu FM; Kogon B; Earing MG; Aboulhosn JA; Broberg CS; John AS; Harmon A; Sainani NI; Hill AJ; Odze RD; Johncilla ME; Ukomadu C; Gauvreau K; Valente AM; Landzberg MJ;
J Thorac Cardiovasc Surg; 2017 Mar; 153(3):656-664. PubMed ID: 27955914
[TBL] [Abstract][Full Text] [Related]
13. Hepatic Abnormalities Are Present Before and Early After the Fontan Operation.
Schwartz MC; Glatz AC; Daniels K; Goldberg DJ; Rand E; Epelman MS; Cohen MS
Ann Thorac Surg; 2015 Dec; 100(6):2298-304. PubMed ID: 26343976
[TBL] [Abstract][Full Text] [Related]
14. Progression of liver pathology in patients undergoing the Fontan procedure: Chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma.
Ghaferi AA; Hutchins GM
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1348-52. PubMed ID: 15942576
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome of the Fontan operation in patients with impaired ventricular function.
Kotani Y; Kasahara S; Fujii Y; Yoshizumi K; Oshima Y; Otsuki S; Akagi T; Sano S
Eur J Cardiothorac Surg; 2009 Oct; 36(4):683-7. PubMed ID: 19713119
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of hemostatic and coagulation factor abnormalities in patients undergoing the Fontan operation.
Jahangiri M; Kreutzer J; Zurakowski D; Bacha E; Jonas RA
J Thorac Cardiovasc Surg; 2000 Oct; 120(4):778-82. PubMed ID: 11003762
[TBL] [Abstract][Full Text] [Related]
17. 18 years of the Fontan operation at a single institution: results from 771 consecutive patients.
Rogers LS; Glatz AC; Ravishankar C; Spray TL; Nicolson SC; Rychik J; Rush CH; Gaynor JW; Goldberg DJ
J Am Coll Cardiol; 2012 Sep; 60(11):1018-25. PubMed ID: 22818071
[TBL] [Abstract][Full Text] [Related]
18. Liver and cardiac function in the long term after Fontan operation.
Camposilvan S; Milanesi O; Stellin G; Pettenazzo A; Zancan L; D'Antiga L
Ann Thorac Surg; 2008 Jul; 86(1):177-82. PubMed ID: 18573420
[TBL] [Abstract][Full Text] [Related]
19. Intra/extracardiac fenestrated modification leads to lower incidence of arrhythmias after the Fontan operation.
Sinha P; Zurakowski D; He D; Yerebakan C; Freedenberg V; Moak JP; Jonas RA
J Thorac Cardiovasc Surg; 2013 Mar; 145(3):678-82. PubMed ID: 22578898
[TBL] [Abstract][Full Text] [Related]
20. Hepatic Fibrosis Is Universal Following Fontan Operation, and Severity is Associated With Time From Surgery: A Liver Biopsy and Hemodynamic Study.
Goldberg DJ; Surrey LF; Glatz AC; Dodds K; O'Byrne ML; Lin HC; Fogel M; Rome JJ; Rand EB; Russo P; Rychik J
J Am Heart Assoc; 2017 Apr; 6(5):. PubMed ID: 28446492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
